Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Central Nervous System Metastases|HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: lapatinib ditosylate|DRUG: everolimus|DRUG: capecitabine|OTHER: laboratory biomarker analysis
Sponsor: Jonsson Comprehensive Cancer Center